In brief: GTG, Resonance Health, Sirtex
Thursday, 07 July, 2005
Genetic Technologies (ASX:GTG) has settled all of its disputes with the Auckland District Health Board, as the representative of all the New Zealand district health boards plus the New Zealand Blood Service. The disputes related to lawsuits filed in New Zealand in 2004 by ADHB against Genetic Technologies' non-coding DNA analysis patent and genomic mapping patent.
Resonance Health (ASX:RHT) has expanded its Medical Advisory Board with new members Dr Bruce Bacon, Dr John Olynyk and Dr John Porter joining current member Dr Kris Kowdley. Dr Chris Bennett has resigned from her position on the former Inner Vision Biometrics Medical Advisory Board but remains as a non-executive director of Resonance Health.
Sirtex Medical (ASX:SRX) has appointed Angela Talbot as its chief financial officer.
Free meningococcal B vaccines coming to the NT
The Northern Territory Government has confirmed the rollout of a free meningococcal B vaccine...
Mouth bacteria linked to increased head and neck cancer risk
More than a dozen bacterial species that live in people's mouths have been linked to a...
Life expectancy gains are slowing, study finds
Life expectancy at birth in the world's longest-living populations has increased by an...
